• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2型再次感染之前存在独特生物标志物,且与初次感染时间及严重程度相关:一项基于国家COVID-19合作临床病例注册(N3C)中电子健康记录的队列研究

SARS-CoV-2 Reinfection is Preceded by Unique Biomarkers and Related to Initial Infection Timing and Severity: an N3C RECOVER EHR-Based Cohort Study.

作者信息

Hadley Emily, Yoo Yun Jae, Patel Saaya, Zhou Andrea, Laraway Bryan, Wong Rachel, Preiss Alexander, Chew Rob, Davis Hannah, Chute Christopher G, Pfaff Emily R, Loomba Johanna, Haendel Melissa, Hill Elaine, Moffitt Richard

机构信息

RTI International, Durham, NC, US.

Stony Brook University, Stony Brook, NY, US.

出版信息

medRxiv. 2023 Jan 5:2023.01.03.22284042. doi: 10.1101/2023.01.03.22284042.

DOI:10.1101/2023.01.03.22284042
PMID:36656776
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9844020/
Abstract

Although the COVID-19 pandemic has persisted for over 2 years, reinfections with SARS-CoV-2 are not well understood. We use the electronic health record (EHR)-based study cohort from the National COVID Cohort Collaborative (N3C) as part of the NIH Researching COVID to Enhance Recovery (RECOVER) Initiative to characterize reinfection, understand development of Long COVID after reinfection, and compare severity of reinfection with initial infection. We validate previous findings of reinfection incidence (5.9%), the occurrence of most reinfections during the Omicron epoch, and evidence of multiple reinfections. We present novel findings that Long COVID diagnoses occur closer to the index date for infection or reinfection in the Omicron BA epoch. We report lower albumin levels leading up to reinfection and a statistically significant association of severity between first infection and reinfection (chi-squared value: 9446.2, p-value: 0) with a medium effect size (Cramer's V: 0.18, DoF = 4).

摘要

尽管新冠疫情已持续两年多,但对新冠病毒再次感染的情况仍了解不足。我们使用了来自国家新冠队列协作组(N3C)基于电子健康记录(EHR)的研究队列,作为美国国立卫生研究院“研究新冠以促进康复”(RECOVER)倡议的一部分,来描述再次感染的特征,了解再次感染后长期新冠的发展情况,并比较再次感染与初次感染的严重程度。我们验证了之前关于再次感染发生率(5.9%)、奥密克戎时期大多数再次感染的发生情况以及多次再次感染证据的研究结果。我们还呈现了新的研究发现,即在奥密克戎BA时期,长期新冠诊断更接近感染或再次感染的索引日期。我们报告了再次感染前白蛋白水平较低,以及初次感染和再次感染之间严重程度存在统计学显著关联(卡方值:9446.2,p值:0),效应大小为中等(克莱默V系数:0.18,自由度 = 4)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dc1/9844020/01388ed8af42/nihpp-2023.01.03.22284042v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dc1/9844020/0c4776598d18/nihpp-2023.01.03.22284042v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dc1/9844020/fe5d248bd9e9/nihpp-2023.01.03.22284042v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dc1/9844020/01388ed8af42/nihpp-2023.01.03.22284042v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dc1/9844020/0c4776598d18/nihpp-2023.01.03.22284042v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dc1/9844020/fe5d248bd9e9/nihpp-2023.01.03.22284042v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dc1/9844020/01388ed8af42/nihpp-2023.01.03.22284042v1-f0003.jpg

相似文献

1
SARS-CoV-2 Reinfection is Preceded by Unique Biomarkers and Related to Initial Infection Timing and Severity: an N3C RECOVER EHR-Based Cohort Study.严重急性呼吸综合征冠状病毒2型再次感染之前存在独特生物标志物,且与初次感染时间及严重程度相关:一项基于国家COVID-19合作临床病例注册(N3C)中电子健康记录的队列研究
medRxiv. 2023 Jan 5:2023.01.03.22284042. doi: 10.1101/2023.01.03.22284042.
2
Insights from an N3C RECOVER EHR-based cohort study characterizing SARS-CoV-2 reinfections and Long COVID.一项基于N3C RECOVER电子健康记录的队列研究对SARS-CoV-2再感染和长期新冠的见解。
Commun Med (Lond). 2024 Jul 11;4(1):129. doi: 10.1038/s43856-024-00539-2.
3
Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study.新加坡一项全国性队列研究:SARS-CoV-2 感染和疫苗对有医疗记录的奥密克戎 BA.4、BA.5 和 XBB 再感染相关症状的保护免疫作用。
Lancet Infect Dis. 2023 Jul;23(7):799-805. doi: 10.1016/S1473-3099(23)00060-9. Epub 2023 Mar 13.
4
SARS-CoV-2 Reinfections in Health-Care Workers, 1 March 2020-31 January 2023.2020 年 3 月 1 日至 2023 年 1 月 31 日期间医护人员中 SARS-CoV-2 再感染情况。
Viruses. 2023 Jul 14;15(7):1551. doi: 10.3390/v15071551.
5
Incidence and severity of SARS-CoV-2 reinfection, a multicenter cohort study in Shanghai, China.中国上海一项多中心队列研究的 SARS-CoV-2 再感染发生率和严重程度。
J Med Virol. 2023 Aug;95(8):e28997. doi: 10.1002/jmv.28997.
6
Protection of hybrid immunity against SARS-CoV-2 reinfection and severe COVID-19 during periods of Omicron variant predominance in Mexico.在墨西哥奥密克戎变异株占主导地位期间,混合免疫对 SARS-CoV-2 再感染和重症 COVID-19 的保护作用。
Front Public Health. 2023 Apr 4;11:1146059. doi: 10.3389/fpubh.2023.1146059. eCollection 2023.
7
Risk of SARS-CoV-2 reinfection by vaccination status, predominant variant and time from prior infection: a cohort study, Reggio Emilia province, Italy, February 2020 to February 2022.疫苗接种状态、主要变异株和既往感染后时间对 2020 年 2 月至 2022 年 2 月意大利雷焦艾米利亚省 SARS-CoV-2 再感染风险的影响:一项队列研究。
Euro Surveill. 2023 Mar;28(13). doi: 10.2807/1560-7917.ES.2023.28.13.2200494.
8
Incidence, Risk, and Severity of SARS-CoV-2 Reinfections in Children and Adolescents Between March 2020 and July 2022 in Serbia.2020 年 3 月至 2022 年 7 月塞尔维亚儿童和青少年中 SARS-CoV-2 再感染的发生率、风险和严重程度。
JAMA Netw Open. 2023 Feb 1;6(2):e2255779. doi: 10.1001/jamanetworkopen.2022.55779.
9
SARS-CoV-2 reinfections in the pediatric cohort-a single-center experience.儿童队列中 SARS-CoV-2 的再感染:一项单中心经验。
J Trop Pediatr. 2023 Dec 6;70(1). doi: 10.1093/tropej/fmad049.
10
Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study.医护人员中,mRNA 疫苗接种与未接种者,初次感染奥密克戎(B.1.1.529)BA.1 或 前奥密克戎 SARS-CoV-2 对 BA.2 再感染的保护作用:一项病例对照研究。
Lancet Infect Dis. 2023 Jan;23(1):45-55. doi: 10.1016/S1473-3099(22)00578-3. Epub 2022 Sep 21.

引用本文的文献

1
Increased galanin-galanin receptor 1 signaling, inflammation, and insulin resistance are associated with affective symptoms and chronic fatigue syndrome due to long COVID.加兰素-加兰素受体1信号增强、炎症和胰岛素抵抗与长期新冠导致的情感症状及慢性疲劳综合征有关。
PLoS One. 2025 Mar 6;20(3):e0316373. doi: 10.1371/journal.pone.0316373. eCollection 2025.

本文引用的文献

1
Coding long COVID: characterizing a new disease through an ICD-10 lens.长新冠编码:通过 ICD-10 视角描述一种新疾病。
BMC Med. 2023 Feb 16;21(1):58. doi: 10.1186/s12916-023-02737-6.
2
SARS-CoV-2 reinfections during the first three major COVID-19 waves in Bulgaria.SARS-CoV-2 再感染在保加利亚前三次 COVID-19 大流行期间。
PLoS One. 2022 Sep 9;17(9):e0274509. doi: 10.1371/journal.pone.0274509. eCollection 2022.
3
Clinical and epidemiological features of patients with COVID-19 reinfection: a systematic review.新冠病毒二次感染患者的临床和流行病学特征:一项系统综述
New Microbes New Infect. 2022 Jul;48:101021. doi: 10.1016/j.nmni.2022.101021. Epub 2022 Aug 28.
4
Rate of SARS-CoV-2 Reinfection During an Omicron Wave in Iceland.冰岛奥密克戎波期间 SARS-CoV-2 再感染率。
JAMA Netw Open. 2022 Aug 1;5(8):e2225320. doi: 10.1001/jamanetworkopen.2022.25320.
5
Risk and severity of SARS-CoV-2 reinfections during 2020-2022 in Vojvodina, Serbia: A population-level observational study.2020 - 2022年塞尔维亚伏伊伏丁那地区新冠病毒再次感染的风险与严重程度:一项基于人群水平的观察性研究
Lancet Reg Health Eur. 2022 Sep;20:100453. doi: 10.1016/j.lanepe.2022.100453. Epub 2022 Jul 1.
6
COVID-19 reinfection: A multicenter retrospective study in Saudi Arabia.新型冠状病毒肺炎再次感染:沙特阿拉伯的一项多中心回顾性研究。
Ann Thorac Med. 2022 Apr-Jun;17(2):81-86. doi: 10.4103/atm.atm_74_22. Epub 2022 Apr 19.
7
Multiple SARS-CoV-2 Reinfections: A Case Series of Thrice-Infected Individuals.新型冠状病毒2型多次重复感染:三重重症感染病例系列
Mayo Clin Proc. 2022 May;97(5):1021-1023. doi: 10.1016/j.mayocp.2022.03.003. Epub 2022 Mar 11.
8
Reinfection in patients with COVID-19: a systematic review.COVID-19 患者再感染:系统评价。
Glob Health Res Policy. 2022 Apr 29;7(1):12. doi: 10.1186/s41256-022-00245-3.
9
Harmonizing units and values of quantitative data elements in a very large nationally pooled electronic health record (EHR) dataset.协调大型全国性电子健康记录(EHR)数据集内定量数据元素的单位和值。
J Am Med Inform Assoc. 2022 Jun 14;29(7):1172-1182. doi: 10.1093/jamia/ocac054.
10
Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa.南非出现奥密克戎后,SARS-CoV-2 再感染的风险增加。
Science. 2022 May 6;376(6593):eabn4947. doi: 10.1126/science.abn4947.